1-1 of 1
Legarff-Tavernier Magali
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CLL2007FMP, a Phase III Randomized Multicentric Trial of the French Cooperative Group On CLL and WM (FCGCLL/MW) and the “Groupe Ouest-Est D'etudes Des Leucémies Aigües Et Autres Maladies Du Sang” (GOELAMS): Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Yields a Significantly Better Response Than Fludarabine (F), Cyclophosphamide (C) and MabCampath (Cam) (FCCam) In Previously Untreated B-Chronic Lymphocytic Leukemia Patients as Evaluated by a Sensitive 6 Color Flow Cytometry MRD

Letestu Remi, Stéphane Leprêtre, MD, Arnoulet Christine, Baseggio Lucille, Campos Lydia, Chatelain Bernard, Jacob marie-Christine, Legac Eric, Legarff-Tavernier Magali, Ticchioni Michel, Robillard Nelly, Delepine Roselyne, Levy Vincent, Katsahian Sandrine, Varet Hugo, Leblond Veronique, Cymbalista Florence, Feugier Pierre, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 698.
https://doi.org/10.1182/blood.V116.21.698.698
Published: 2010